CRISPR-Edited Fibroblasts

Primary Fibroblast KO Pools are made-to-order knockouts with editing efficiencies >80% generated in 4 weeks or faster from receiving IDEXX approved cells. EditCo consistently achieves >90% editing efficiency, creating cell pools that are functionally similar to a clone. As primary cell clones are biologically difficult to produce, EditCo’s high editing efficiency provides a unique approach to generating cell populations of interest.

Whether you are leveraging CRISPR for validating targets for drug discovery or modeling a biological process for the investigation of a novel gene of interest, failed experiments lead to a loss of time and resources. EditCo’s Primary Fibroblast KO Pools are the solution for obtaining quick and reliable functional data while reducing the risk for false negatives in your critical assays.

EditCo’s proprietary editing protocols deliver high-efficiency edits at scale. Our Knockout Fibroblast Cells, powered by XDel Technology, provide researchers with the confidence and reproducibility they need for guaranteed CRISPR knockouts.

Edited Fibroblast Cell Options

For Additional Information on our Primary Fibroblast offering, download our flyer below.

EditCo’s made-to-order knockout fibroblast services enable you to further research in CNS disorders, wound healing, cystic fibrosis, autoimmunity, cancer, or other disease areas where fibroblasts have been implicated.

Furthermore, EditCo’s extensive Discovery Partners Ecosystem creates a seamless workflow from EditCo’s CRISPR engineered cells to phenotypic data, providing researchers with a faster, more efficient, and more reliable way to drive their discoveries forward.